HOME >> MEDICINE >> NEWS
Scientists identify cells responsible for relapse after treatment in common childhood cancer

Approximately 20% of children with ALL will experience a relapse of their disease following treatment. Of these, most will never be cured.

"We have previously shown that these relapses were due to small numbers of cells which survived the treatment administered to the patient," said Prof Norris.

"However, it has been unclear whether these cells developed resistance to chemotherapy during the course of treatment or if they were already present in the child at the time their cancer was diagnosed."

The findings of this study demonstrate that relapse in ALL patients can result from a minor, but intrinsically resistant subpopulation of cells, present from the time of diagnosis. Undetected at diagnosis because of their very small numbers, this population of leukaemia cells remained in the patients body throughout the disease and continued to thrive even after the major population of sensitive leukaemia cells were destroyed and the patient appeared to have gone into remission.

"We have shown, for the first time, that children with a greater number of these cells at diagnosis are more likely to experience relapse much sooner after treatment.

"Without new strategies to identify and attack these cells early in treatment, relapse appears inevitable for these patients," said Prof Norris.

"Our ability to characterise these cells means that researchers can now develop treatments which specifically target the cells and are more effective than current options."


'"/>

Contact: Pearly Harumal
61-293-828-823
Research Australia
29-Mar-2007


Page: 1

Related medicine news :

1. Scientists train nano-building blocks to take on new shapes, as reported in Science
2. Scientists find war vets hand dexterity determines susceptibility to PTSD
3. Scientists develop method to track immune system enzyme in live animals
4. Scientists from the CIMA investigate a molecule for diagnosing hypertensive cardiopathy
5. Scientists equip bacteria with custom chemo-navigational system
6. Scientists find missing link to understand how plants make vitamin C
7. Scientists and polar explorers brave the elements in support of CryoSat-2
8. Scientists progress in successful tissue engineering
9. Scientists re-grow dental enamel from cultured cells
10. Scientists create dual-modality microbeads to improve identification of disease biomarkers
11. Scientists develop method to remove prion infectivity from scrapie-infected blood

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/5/2018)... Pa. (PRWEB) , ... October ... ... the award-winning, multi-channel medical broadcasting company delivering education to healthcare professionals through ... web and mobile destination designed exclusively for rheumatologists. , "This is ...
(Date:10/3/2018)... MILWAUKEE (PRWEB) , ... October 03, 2018 , ... ... first mobile clinical tool to allow OB/GYNs to remotely monitor their pregnant patients’ ... the Froedtert & Medical College of Wisconsin health network (MCW). Patients who choose ...
(Date:10/3/2018)... ... October 03, 2018 , ... Tranquil Care Hospice, the only ... been awarded CHAP (Community Health Accreditation Partner, Inc.) Accreditation under the CHAP Hospice ... deemed to meet the Medicare Conditions of Participation and is certified as a ...
(Date:10/3/2018)... ... October 03, 2018 , ... Intellimed ... – a web-based tool that provides turnkey strategic direction based upon the ... and marketing groups can quickly query diagnostic (DX) and procedure (PX) codes ...
(Date:10/2/2018)... ... 02, 2018 , ... Today, AngelMD is announcing the close of a $594,000 ... total $3.4 million round that has now been closed by the company. , ... However, the status quo for PICC equipment has an inherent problem -- the potential ...
Breaking Medicine News(10 mins):
(Date:10/13/2018)... , ... October 12, 2018 , ... ... on July 7, 1987 which was used in the Lockheed F22 Aircraft. Today, ... between controlled and uncontrolled AF-Arrhythmia, which can lead to sudden cardiac death (SCD). ...
(Date:10/13/2018)... ... October 13, 2018 , ... In the world of contract ... massive brand after another. 2018 has been a game-changing year for Ion Labs ... a large role in the growth. Ion Labs attributes its growth to its responsiveness ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... announced today that it has completed the strategic combination of RevSpring and ... patient revenue cycle engagement, billing, and payments solutions generating over one billion ...
Breaking Medicine Technology:
Cached News: